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The human intestinal flora is a highly diverse and complex microbial ecosystem. This 
microbiome changes drastically in CF patients due to the frequent and combined 
antibiotic usage. Moreover, the decreased release of digestive enzymes by the 
pancreatic duct leads to a different alimentary environment in which the microbial 
system resides. A shotgun metaproteomics approach is used to characterize the 
predominant members of the intestinal microbiota of a group of cystic fibrosis patients 
compared with the flora of siblings.  
 
The aim of this study was to evaluate a metaproteomics pipeline (gel-LC-ESI-FT-
MS/MS) on samples extracted from feces of a CF patient and its sibling. Two 
fractions were separated by 12.5 % SDS-PAGE. After reduction and alkylation, the 
complete lanes were cut from the gel and sliced into 6 bands per lane. Each band 
was in-gel digested and peptides were first separated on an Agilent 1200 
chromatographic system (Agilent, Santa Clara, CA, USA) and on-line measured on a 
LTQ-FT Ultra mass spectrometer (Thermo Fisher Scientific, Waltham, MA, USA). 
Raw LC-ESI-FT-MS/MS data were searched against the NCBInr database and a 
decoy database using Mascot Daemon. The characterization of the predominant 
members of the intestinal microbiota was performed using a novel approach for 
identifying taxon-specific peptides (Unipept). 
 
Our preliminary data point to a decrease in species richness and in less unique 
peptides originating from Firmicutes, Proteobacteria and the 
Bacteroidetes/Chlorobium group in the microbiota of the CF patient compared to the 
sibling. Similar findings are also reported in a recent microbiological study 
(Duytschaever et al, 2011) on fecal samples of CF patients.  Furthermore, the 
detection of unique peptides of Viridiplantae indicates incomplete digestion of food in 
the intestinal tract. The unique peptides from Sus scrofa in the CF patient can be 
explained by the presence of pancreatin, a mixture of the pancreatic enzymes lipase, 
amylase and protease extracted from pig (Sus scrofa) pancreas glands.  
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